Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 May 15;204(2):377-81.
doi: 10.1042/bj2040377.

A new Kupffer cell receptor mediating plasma clearance of carcinoembryonic antigen by the rat

A new Kupffer cell receptor mediating plasma clearance of carcinoembryonic antigen by the rat

C A Toth et al. Biochem J. .

Abstract

Native human carcinoembryonic antigen is rapidly removed from the circulation by the rat liver Kupffer cell after intravenous injection. The molecule is subsequently transferred to the hepatocyte in an immunologically identifiable form. Carcinoembryonic antigen has a circulatory half-life of 3.7 (+/- 0.8) min, and cellular entry is by receptor-mediated endocytosis. Non-specific fluid pinocytosis and phagocytosis can be excluded as possible mechanisms by the kinetics of clearance and failure of colloidal carbon to inhibit uptake. Substances with known affinity for the hepatic receptors for mannose, N-acetylglucosamine, fucose and galactose all fail to inhibit carcinoembryonic antigen clearance. After two cycles of the Smith degradation, carcinoembryonic antigen is still able to inhibit clearance of the native molecule. Receptor specificity is apparently not dependent on those non-reducing terminal sugars of the native molecule. Performic acid-oxidized carcinoembryonic antigen also inhibits clearance of carcinoembryonic antigen in vivo. Receptor binding is not dependent on tertiary protein conformation. Non-specific cross-reacting antigen, a glycoprotein structurally similar to carcinoembryonic antigen, is cleared by the same mechanism.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Gastroenterol. 1976 Sep;5(3):625-38 - PubMed
    1. J Exp Med. 1965 Mar 1;121:439-62 - PubMed
    1. Br J Cancer. 1978 Feb;37(2):183-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1670-4 - PubMed
    1. Biochem J. 1978 Sep 1;173(3):981-3 - PubMed

Publication types